Copy
MabDesign News 
Newsletter n°8 -October 21st, 2016
View this email in your browser
In this Issue:
 
We have set-up a new unique directory tool just for you. Do not miss this opportunity to promote your expertise on the MabDesign Directory. Join the Directory now!

We have 2 sessions of Target Product Profile training course in Paris and Lyon.
Don't miss it!

Moreover, we have developed special for you a Strategic Marketing Service.
Check it out!

Also take a loot at the upcoming events to book your Agenda!


Finally read the latest news about MabDesign Members !
 
Wish you good reading,
MabDesign Team
Discover the MabDesign Expertise Directory !
Join the Directory Now !
MabDesign has created a unique nationwide directory dedicated to the French stakeholders working in the immunotherapy field.

 This tool has been created in order to :
1) allow the position of your company expertise on the immunotherapy value chain;
2) help you to identify potential partners/clients;
3) increase your company visibility worldwide. 

Join now the MabDesign Directory to start to benefit from this great tool made special for You !
Target Product Profile (TPP)
a strategic development process tool, originally developed as a joint collaboration between the FDA and the biopharmaceutical industry

2 Training Sessions!
Wednesday November 23, 2016 I Lyon
Wednesday December 7, 2016 I Paris
Benefit of an exclusive offer before October 31 to the Paris session
Member fee : 600 € - Non-member fee : 750 €
Normal fee
Member fee : 700€ - Non-member fee: 850€


Places limited to 15 participants!
 
TPP session in Lyon - Wednesday, November 23th, 2016
Download the program
Register to the TPP session in Lyon!
TPP session in Paris - Wednesday, December 7th, 2016
Download the program
Register to the TPP session in Paris!
More information: formation@mabdesign.fr
MabDesign’s Strategic Marketing Service

Looking for market insight and strategic advice to support your service or therapeutic product development?
MabDesign has prepared a strategic marketing service to its members.
Download now our brochures for service providers and therapeutic product developers !
MabDesign, represented by its CEO, Francis Carré, participated at the 5th G5 French Health Meeting as a speaker at the round table "How to maintain and develop the production of health products in France?" that took place at Institut IMAGINE, Paris on October 10th 2016. Read more...
Registration and BtoB meetings set-up until November 8th !
Join the Research2Business Oncology Meeting 2016 which will take place on November 15th, in Lyon, France, dedicated to collaborative R&D and open-innovation.

Plenary Session co-organized with MabDesign
“Immuno-Oncology: latest advances, stakes, challenges & partnership opportunities”

Invited speakers:
Marc BONNEVILLE (Institut Mérieux) - Chairman
Éric VIVIER (Marseille-Luminy Immunology Center)
Liliane GOETSCH (Pierre FABRE Immunology Center)
SANOFI,
Stéphane DALLE (Lyon Civil Hospitals/ Cancer Center of Lyon),
Claudine VERMOT-DESROCHES (iDD biotech)
Manuel VELASCO and Vincent SERRA (Pierre FABRE Médicament)

Seize the opportunity to expand your network and initiate future partnerships around innovative oncology projects!

Registration  
UPCOMING EVENTS

EpiVax Seminar on Immunogenicity and Tolerance
Amsterdam October 24th, 2016

 
EpiVax is organizing their 2nd seminar on Immunogenicity and Tolerance on October 24th, 2016 in Amsterdam.
This meeting will focus on the determinants of immunogenicity – a key feature of effective vaccines and a key barrier to success in the clinic for protein therapeutics. Conversely, tolerance induction is a key feature of successful protein therapeutics, while suppressing immune responses to vaccines. The reduction of T cell epitopes and introduction of Treg epitopes (like Tregitopes) for protein therapeutics, and the reverse process for vaccines, will be discussed and illustrated in case studies. 
An award will be given for the most innovative research program or product!
Click to register  I
  To know more visit : EpiVax Seminar
Cisbio is pleased to sponsor a complimentary seminar on “Addressing Drug Discovery Challenges in GPCR Signaling”, featuring key experts in the field of GPCR pharmacology and signaling. This seminar will take place on Friday 27 October at the Institut Cochin.
More info and registration
PEGS Europe  - Oct. 31 - Nov 4, 2016 - Lisbon, Portugal
MabDesign will be attending this event.
Get in touch with us if you would like to meet us there! Read more...
BIO-EUROPE 2016 - Nov. 7-9, 2016 - Cologne, Germany
MabDesign will be attending this event.
Get in touch with us if you would like to meet us there! Read more...
European Antibody Congress - Nov. 14-16, 2016 - Basel, Swiss
MabDesign will be attending this event.
Get in touch with us if you would like to meet us there! Read more ...
R2B Oncology Meeting - CLARA
Lyon - 15 November 2016
MabDesign is partner of this edition dedicated to Immuno-Oncology.
Registration Deadline : 8 November 2016 . Register Now !

Cell Therapy Manufacturing & Gene Therapy Congress

Amsterdam - 29-30 November 2016
 
As a  MabDesign member you are entitled to an exclusive 25% discount (not applicable to supplier/vendor) to attend the event. To claim the discount, just send us an email  I To know more visit : Cell Therapy Congress
BioFit - Nov. 30- Dec. 1, 2016 - Lille, France
MabDesign will be attending this event.
Get in touch with us if you would like to meet us there! Read more...
World ADC Berlin
20-23 February 2017, Berlin

www.worldadc-europe.com/
 
Bringing together 60+ thought leaders in the ADC field; you will hear their lessons learned, discuss new data and debater future opportunities.
MabDesign members have an exclusive 20% discount on the registration fees.
Contact us to obtain the code !
Next Gen Immuno-Oncology Congress
London - 14-15 March 2017
This congress brings together  academicians, researcher and scientist to discuss the growth of current therapeutics and pave way for emerging next generation therapeutics.
MabDesign members have an exclusive 20% discount on registration fees.
Contact us to receive the discount code !
OUR  MEMBERS
More than 70 companies have already joined MabDesign!

Do you know them?

 
I ABL Lyon I ABLIANCE I ACANTHE BIOTECH I  ACCINOV  I  ACTICOR BIOTECH  I ADVANCED BIODESIGN  I  AGILENT  I  AGUETTANT BIOTECH ANAQUANTANTINEO  I ATLANBIO I  ATLANPOLE BIOTHERAPIES  I  AXENIS  I B CELL DESIGNBIOCELLCHALLENGE  I  BIOMUNEX  I BIOTEM  I  BLINKBIOMEDICAL I  CALIXAR I CAMINNOV  I CANCER BIO SANTÉ  I  CARLINA TECH  I  CELLENION  I CISBIOCLEAN CELLS  I  COVALAB  I C.RIS PHARMA I DELPHARM BIOTECH  I  DENDRITICS  I  DYNABIO SA   I  ECRINS THERAPEUTICS  I EIVATECHELSALYS BIOTECH  I  EUROBIOMED  I  FAB'ENTECH I GE HEALTHCARE  I GENEPEP  I  GENOWAY  I   GENTICEL  I  GLYCODIAG  I  GROUPE IMT  I  GTP TECHNOLOGY  I  HISTALIM  I  HYBRIGENICS SERVICES  I  IDD  I  IDD BIOTECH  I  INOVOTION  I  INSTITUT DE RECHERCHE PIERRE FABRE  I  LFB BIOTECHNOLOGIES  I  LYONBIOPOLE  I MAAT PHARMAMC SAF  I  MEDICEN PARIS REGION  I  MERCK BIODEVELOPMENT  I  MIMABS  I  NETRIS PHARMA  I  NOVADISCOVERY  I  NOVASEP  I  OGD2 PHARMA  I  OSE IMMUNOTHERAPEUTICS I PROMISE ADVANCED PROTEOMICS  I PROTEODYNAMICS  I  PX*THERAPEUTICS  I  RD BIOTECH  I  REPROPHARM  I  SANOFI  I  SIAMED’XPRESS  I     SYCOMORE TECHNOLOGIES  I  SYNDIVIA  I  SYNTHELIS  I TEBU-BIO  I  VETOQUINOL  I  VIBIOSPHEN  I VOXCAN
NEWS ABOUT OUR MEMBERS
October 21, 2016 - Merck's KEYNOTE-045 Studying KEYTRUDA® (pembrolizumab) in Advanced Bladder Cancer (Urothelial Cancer) Meets Primary Endpoint and Stops Early. Read more

October 18, 2016 - McSAF recognized as Young Innovative Company. Read more

October 17, 2016 - Scienion Opens French Subsidiary Cellenion with Focus on Controlled Cell Dispensing Technologies. Read more

October 5, 2016 - PX'Therapeutics and RELIEF THERAPEUTICS Holding AG announce a strategic collaboration agreement for the recombinant production of atexakin alfa. Read more

October 4, 2016 - OSE Immunotherapeutics to present the preclinical data of its new checkpoint  Effi-DEM on SIRP-α/CD47 strategic pathway at the 2016 Immune Checkpoint Inhibitors Conference. Read more


October 1, 2016 - Sanofi and Regeneron Announce Positive Dupixent® (dupilumab) Phase 3 Atopic Dermatitis Data Published in The New England Journal of Medicine. Read more

September 30, 2016 - GE Healthcare's Biosafe announces Sefia platform to address multiple steps in cell therapy production process. Read more

September 30, 2016 - Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare. Read more


September 29, 2016 - Siân Crouzet joins MaaT Pharma as COO. Read more

September 27, 2016 - BioCellChallenge reports promising results from its first intravenous assay. Read more
NEWS AROUND THE WORLD
October 20, 2016 - A new compound discovered jointly by Servier and Vernalis shows promise in treating multiple human cancers. Read more

October 19, 2016 - AstraZeneca has contributed to ADC Therapeutics’ €96M fundraising, the biggest round so far in Europe this year
. Read more

October 18, 2016 - J&J eyes immuno-oncology with 15R&D assets. Read more

October 14, 2016 - Ex-Novartis CAR-T research joins TxCell to lead CAR-Treg research program. Read more

October 12, 2016 - Merck KGaA in trangene cancer vaccine-checkpoint inhibitor test tie-up. Read more

October 5, 2016 - Chugai's 
ACTEMRA®/RoACTEMRA® receives breakthrough theray designation for US FDA for giant cell arteritis. Read more

September 29, 2016 - Biotech is one of the biggest Employers in Europe. Read more

September 28, 2016 - GSK and Oncondesign announce agreement for Oncodesign's acquisition of GSK's Research Centre in France. Read more

Read more News on Antibodies : PipelineReview
Copyright © 2016 - MabDesign, All rights reserved.